249 filings
Page 10 of 13
8-K
hh5rd39
25 Feb 11
Other Events
12:00am
8-K
t95xax0btsl0azhntd6
25 Jan 11
Other Events
12:00am
8-K
5xcu0elf760 mt24o
22 Dec 10
Threshold Pharmaceuticals Announces Promising Early Phase 1 Clinical Trial Results In Patients with Advanced Leukemias
12:00am
8-K
wzh 6kbfmur002u
19 Nov 10
Other Events
12:00am
8-K
umkuqfbk
15 Nov 10
Other Events
12:00am
8-K
cnidnmaj
29 Oct 10
Entry into a Material Definitive Agreement
12:00am
8-K
f6rhca6zhzv ip7uw5am
12 Oct 10
Other Events
12:00am
8-K
doy sqf7n
1 Jul 10
Other Events
12:00am
8-K
z458 6gw10pp5eygh
29 Jun 10
Other Events
12:00am
8-K
9dijt
8 Jun 10
Threshold Pharmaceuticals Presents Promising Clinical Trial Results Demonstrating Broad Anti-tumor Activity
12:00am
8-K
3n5qu8ylawdznycmi
1 Jun 10
Departure of Directors or Certain Officers
12:00am
8-K
3ssbo n2p64
20 May 10
Submission of Matters to a Vote of Security Holders
12:00am
8-K
y1xzta05dq l8su52e
12 May 10
Threshold Pharmaceuticals Appoints DR. David R. Parkinson to Board of Directors
12:00am
8-K
s0a7uaq
31 Mar 10
Entry into a Material Definitive Agreement
12:00am
8-K
rvmx0
4 Mar 10
Threshold Pharmaceuticals Reports Fourth Quarter and Year End 2009 Financial Results
12:00am
8-K
poo63ewlj mac58l2
26 Jan 10
Threshold Presents Clinical Trial Data from a Phase 1/2 Clinical Trial of TH-302 at Asco Gastrointestinal Conference
12:00am
8-K
ig5mna
13 Jan 10
Other Events
12:00am
8-K
3yeblw00
20 Nov 09
Departure of Directors or Certain Officers
12:00am
8-K
7oxc9el9k 1ltemoh
18 Nov 09
Other Events
12:00am
8-K
5cbz 50meev2
9 Nov 09
Threshold Pharmaceuticals Presents Interim Data from a Phase 1/2 Clinical Trial of TH-302 at Sarcoma Meeting
12:00am